RAMM Pharma Price To Sales vs. Total Debt
| RAMMFDelisted Stock | USD 0.06 0.00 0.00% |
For RAMM Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of RAMM Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well RAMM Pharma Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between RAMM Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of RAMM Pharma Corp over time as well as its relative position and ranking within its peers.
RAMM |
RAMM Pharma Corp Total Debt vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining RAMM Pharma's current stock value. Our valuation model uses many indicators to compare RAMM Pharma value to that of its competitors to determine the firm's financial worth. RAMM Pharma Corp is rated fourth in price to sales category among its peers. It is rated fifth in total debt category among its peers making up about 2,151 of Total Debt per Price To Sales. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the RAMM Pharma's earnings, one of the primary drivers of an investment's value.RAMM Total Debt vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
RAMM Pharma |
| = | 4.04 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
RAMM Pharma |
| = | 8.69 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
RAMM Total Debt vs Competition
RAMM Pharma Corp is rated fifth in total debt category among its peers. Total debt of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 10.43 Million. RAMM Pharma adds roughly 8,690 in total debt claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
RAMM Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in RAMM Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, RAMM Pharma will eventually generate negative long term returns. The profitability progress is the general direction of RAMM Pharma's change in net profit over the period of time. It can combine multiple indicators of RAMM Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada. Ramm Pharma is traded on OTC Exchange in the United States.
RAMM Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on RAMM Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of RAMM Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the RAMM Pharma's important profitability drivers and their relationship over time.
Use RAMM Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RAMM Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAMM Pharma will appreciate offsetting losses from the drop in the long position's value.RAMM Pharma Pair Trading
RAMM Pharma Corp Pair Trading Analysis
The ability to find closely correlated positions to RAMM Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace RAMM Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back RAMM Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling RAMM Pharma Corp to buy it.
The correlation of RAMM Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as RAMM Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if RAMM Pharma Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for RAMM Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your RAMM Pharma position
In addition to having RAMM Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SPAC Thematic Idea Now
SPAC
Entities that are involved in raising capital, merging with and acquiring companies, and investing in private equity through leveraged buyouts. The SPAC theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SPAC Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in RAMM Pink Sheet
If you are still planning to invest in RAMM Pharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RAMM Pharma's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |